Trade Summary

12 months ago, Salkind Gene, serving as Dir, 10% owner at Upexi, Inc. (UPXI), purchased 20,243 shares at $4.94 per share, for a total transaction value of $100,000.00. Following this transaction, Salkind Gene now holds 585,370 shares of UPXI.

This purchase represents a 4.00% increase in Salkind Gene's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, July 11, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, July 30, 2025 at 12:47 PM ET, 19 days after the trade was made.

Upexi, Inc. operates in the COMMUNICATION SERVICES sector, specifically within the INTERNET CONTENT & INFORMATION industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.